Merck Seeks To Dismiss Gardasil Lawsuits, Claiming They Are Preempted by Federal Law
Motion asks the court to dismiss all 16 Gardasil IVC vaccine lawsuits selected to serve as bellwether test trials in the federal MDL.
Motion asks the court to dismiss all 16 Gardasil IVC vaccine lawsuits selected to serve as bellwether test trials in the federal MDL.
Gardasil lawsuit claims HPV injections resulted in permanent injuries, debilitation, pain and exhaustion.
Fosamax femur fracture lawsuits will be returned to the U.S. District Court in New Jersey, where the litigation was consolidated more than 13 years ago.
Findings come as Merck faces a growing number of Gardasil lawsuits brought by parents and young adults who say they suffered severe injuries due to side effects of the HPV vaccine injections.
While Keytruda is widely used to treat various forms of cancer, studies in recent years have frequently linked the Merck drug to severe side effects.
Lawsuits allege that Merck hid the link between Gardasil and autoimmune disorders for years, making it difficult to file with the U.S. Vaccine Court in a timely manner.
Some lawsuits over the Gardasil were filed more than three years after the HPV vaccine was administered to plaintiffs as children, since it was not discovered that the vaccine caused autoimmune problems for many years.
Male and female patients reacted differently to Gardasil injections, with women reporting a higher number of adverse health events.
Lawsuits were dismissed after MDL Judge found that a specific DNA test was required to establish the vaccine Zostavax caused shingles, which plaintiffs argued was an impossible standard.
Lawyers are scheduled to meet on Thursday with the U.S. District Judge presiding over hundreds of other Gardasil lawsuits, as preparations continue for the first federal bellwether trials.